B4GALT1 and neoplasm: This downregulation of B4GALT1 could reduce NOTCH signalling due to the reduced galactose activity (212) and thus inhibit the tumour suppressor activity of NOTCH signalling such as reducing the innate and adaptive immune response or reducing the p53 checkpoint protein (213).